Panbela Therapeutics, Inc. PBLA
Set alert
0.01 USD 0.00 0.00%
At close · Oct 30
0.02 Day range 0.02
0.0001 52-week range 2.50
- YTD
- +5,450.00%
- 1 year
- +5,450.00%
- Open
- 0.02
- Prev close
- 0.0111
- Mkt cap
- 53.89K
- Vol
- 1.01K
- Avg vol
- 756
- EPS
- -1,915.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.02
- High
- 0.02
- Forward P/E
- -0.02
- Beta
- 0.82
- Short ratio
- 0.07
- Inst. own
- 0.60%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.07
- 200-d avg
- 30.69
- 1y target
- 410.00
Analyst view
Consensus: buy
Buy
Price target (mean) 410.00 +3693593.7% upside
Now 0.0111
- Target (low)
- 320.00
- Target (mean)
- 410.00
- Target (high)
- 500.00
Recommendation trend
- 1 month ago 2
- 2 months ago 2
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -24.34 | -28.40 – -20.28 | -3,408.00 | +99.3% | 0 | 0.0% | 2 |
| Next quarter | -1.48 | -1.48 – -1.48 | -390.00 | +99.6% | 0 | 0.0% | 1 |
| Current year | -203.86 | -213.13 – -194.60 | -40,746.00 | +99.5% | 0 | 0.0% | 2 |
| Next year | -34.38 | -63.80 – -4.97 | -203.86 | +83.1% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |